Message from ACMT Leadership
As we reflect on the accomplishments of 2024, we are proud to share with you a year of significant progress, collaboration, and innovation. ACMT continues to grow in both scope and impact, driven by the tireless work of our members and the unwavering commitment to advancing the science and practice of medical toxicology. We highlight a few of this past years’ successes.
We are thrilled to report that the 2024 Annual Scientific Meeting in Washington, DC set a new attendance record, reflecting the growing interest and engagement in medical toxicology. The event provided a dynamic platform for education, networking, and collaboration, marking a truly successful gathering for our community.
In 2024 we launched ACMT Connect, our new online platform designed to enhance communication, networking, and collaboration among members. This initiative represents an important step in creating a more connected and engaged medical toxicology community. If you have not yet ‘connected’ with this platform, feel free to join the conversation. We look forward to hearing from you.
ASM 2024 also presented the launch of the exciting re-configured ‘Shark Tank’ competition funded by the Medical Toxicology Foundation (MTF.) The Shark Tank winner was provided a $20,000 grant fostering a culture of innovation within our community.
The Board of Directors have also been busy. They recently updated our 2024-2029 strategic plan positioning ACMT to tackle emerging challenges in medical toxicology. This plan will guide our activities over the next five years as we strive to expand our influence and impact. In addition, our comprehensive research agenda was published in the Journal of Medical Toxicology (JMT), outlining critical priorities and opportunities for advancing toxicology research. This document will serve as a roadmap for our research efforts and collaborations moving forward. Both the Strategic Plan and our research agenda will help focus our many efforts into the future.
As we continue to grow, ACMT has nurtured ongoing relationships with several national organizations. We were pleased to partner with the Providers Clinical Support System – Medications for Alcohol Use Disorder (PCSS-MAUD) in 2024 to deliver educational resources for clinicians and other healthcare professionals caring for patients confronting Alcohol Use Disorder (AUD.)
In addition, for the first time by ACMT through a collaborative partnership with NIDA, we are incredibly pleased to provide the NIDA-ACMT CTN Dissemination Initiative Mentor-Facilitated Training Program to Drs. Matthew Dernbach (Emory University School of Medicine) and Anthony Spadaro (Rutgers New Jersey Medical School). This award supports the development of dedicated, qualified clinicians who wish to develop expertise in substance use disorder education through a one-year sponsored project and mentorship.
Lastly, in a major milestone, ACMT was awarded a new five-year cooperative agreement with the CDC to build the public health capacity of medical toxicologists.This partnership highlights medical toxicologists’ critical role to play in public health response and will enhance our ability to respond to public health threats and improve toxicological responses across the nation.
These accomplishments and many more reflect the collective strength of our membership and the broadening of our impact on both the medical toxicology field and public health at large. As we move into 2025, we are energized by the opportunities that lie ahead and remain committed to advancing the practice of medical toxicology for the benefit of public health and patient care everywhere.
Many thanks to the tireless work of the ACMT Board of Directors and Staff for all their great work in 2024.

Anthony Pizon, MD, FACMT
ACMT Board President

Paul Wax, MD, FACMT
ACMT Executive Director

Education Report
ACMT Education | Learning in Action

ACMT Education hosted 32 webinars in 2024, delivering over 2,000 minutes of educational content to 3,143 live attendees. These live virtual activities included the Addiction Toxicology Case Conference, National Case Conference, National Grand Rounds, and National Journal Club, showcasing ACMT’s dedication to professional development and collaboration as a key benefit to its members.
Beyond our regularly occurring series, ACMT offered multiple ad hoc webinars including two Bayer-sponsored Medical Toxicology in Industry webinars, two grant writing focused ANTIDOTE webinars, and the inaugural Transatlantic Toxicology Talk with EAPCCT on “Utilizing Fomepizole in Acetaminophen Poisoning.”
With the Learning Center, ACMT was able to offer more continuing education accredited asynchronous learning in 2024 than ever before including, DEA-MATE Act Training, the Forensic Course on “Cannabinoids and Polydrugs” and Symposia on “Self-Harm, Suicidality, and the Poisoned Patient” and “SUD in Adolescents.” With commercial support from BTG International Inc., a SERB Pharmaceuticals company, ACMT introduced a new interactive module on the “Management of Patients with Cardiac Glycoside Toxicity.”
Visit the Learning Center to access our full catalog of webinars, on-demand and upcoming courses and events. You can search by topics that interest you to tailor your unique education experience!
#ACMT2024 in DC was Another Record-Breaking Year –
Here are Some Highlights

ACMT’s 2024 Annual Scientific Meeting in Washington, DC was one of the best yet! Marking another milestone year, the event shattered attendance records with 444 participants hailing from 41 states and 16 different countries. Building upon the success of previous gatherings, this year’s meeting saw a surge in interest, reflected in the 45 responses to our call for plenary proposals and 272 responses to our call for abstracts. In addition to our traditional format, this year’s meeting piloted concurrent topical tracks in Environmental & Occupational Medicine, Addiction Toxicology, DEI, and Research, allowing for more educational content than ever before. We also hosted numerous committee and section meetings, including an extremely popular “FIT DoubleDare Activity” which is sure to become a long-standing tradition.
This year’s Donovan Lectureship featured NIDA Director, Dr. Nora Volkow who spoke on “Groundbreaking Research Addressing the Challenges of the Opioid Epidemic.” And the 2024 ACMT Career Achievement Award went to Dr. Keith Burkhart who spoke about his long and illustrious career at the FDA. Other award recipients include:
Preceding the main conference, the AACT Symposium returned this year with the focus, “Antidote Shortages: Impact & Response” on Wednesday, April 10th, followed by the ACMT Symposium “Substance Use Disorder in Adolescents & Young Adults” on Thursday, April 11th. Both symposia received very positive reviews and were heralded as timely in their choice of topics.
Thank you to all who participated in our 2024 Annual Scientific Meeting and Symposia. A special thank you to conference committee chair, Dr. Kathy Kopec, and the other members of this year’s planning committee. We would also like to acknowledge the important contribution of the Addiction Toxicology Committee in presenting the ACMT Symposium — special thanks to Drs. Leslie Dye, Ashley Haynes, and Robert “Cole” Pueringer. None of this would be possible, of course, without Education Committee Chair, Dr. Diane Calello and Research Committee Chair, Dr. Maryann Amirshahi.
We Congratulate these #ACMT2024 Award Winners

2024 Best Original Research Platform Presentation Award
Joshua D. King, MD, FACMT, Assistant Professor of Medicine and Pharmacy & Medical Director, Maryland Poison Control & University of Maryland School of Medicine, Baltimore, MD
“Complications Limiting Use of Hemodialysis in Salicylate Deaths”

2024 ACMT Early Career Investigator Award
Christopher James Watson, MD, Maine Medical Center, Portland, ME
“N-Acetylcysteine Dosing Strategy and Duration of Therapy in Massive Acetaminophen Overdoses Treated Within Eight Hours”

2024 Best Original Research by a Fellow Award (inaugural award)
Mayank Gupta, MD, Fellow, Emory University School of Medicine, Atlanta, GA
“Octreotide Administration Methods in Sulfonylurea Poisoning: A Retrospective Chart Review”

2024 Best Original Research Lightning Oral Presentation Award
Colleen Cowdery, MD, Fellow, Oregon Health & Science University, Portland, OR
“Calcium Precipitation in Bedside Calcium Gel Mixing for Dermal Hydrofluoric Acid Exposure Treatment”

2024 Best ToxIC Presentation Award
Meghan B. Spyres, MD, FACMT, Banner – University Medical Center Phoenix, Phoenix, AZ
“Analysis of Acute Hypersensitivity Reactions by Antivenom Type by Geographic Location in the North American Snake Bite Registry”

2024 Best Original Research Presented by a Student Award (inaugural award)
Kai Smollin, High School Student, The Bay School of San Francisco, San Francisco, CA
“Will Artificial Intelligence Replace the Medical Toxicologist? Pediatric Referral Guidelines Generated by GPT-4”
Attendee Feedback
- ”This event would have been worth travelling even if it were a single day stand-alone event”
- “Very good. Area needs leadership from groups like ACMT”
- “It was exceptionally helpful having the posters and abstracts available on the app in advance. This made for more efficient and effective discussions with the poster authors during the poster sessions.“
- “Overall it was well run. Even some of the more classically dry subjects such as occupational were made engaging by the particular speakers chosen, which was nice..”
- “Loved the location, topics chosen, and connecting with colleagues/friends.”
- “Breadth of specialty covered was incredible. High quality speakers!”
- “International section had great speakers this year.”
- “I really liked the way sessions were divided by tracks. This made it possible to attend relevant sessions without the fear of it conflicting with each other.”
- “Concurrent sessions were excellent!”
2024 ACMT Education Committee Service Award

This annual award is given to honor a member of the ACMT Education Committee who has displayed excellence in establishing and promoting ACMT’s educational program and who has distinguished themself with volunteer service to the committee.
The 2024 ACMT Education Committee Service Award goes to Dr. Gillian Beauchamp.
Dr. Beauchamp’s contribution to ACMT’s repository of online education materials is immeasurable…but we’re going to try…
In 2017, Dr. Beauchamp who had just completed her MedTox Fellowship the year before, saw a need for some sort of repository or online library of lectures on esoteric medical toxicology topics that may not always be thoroughly covered at all fellowship programs. And so she came up with the MedTox Video Library. And the first year she found 6 volunteers to give lectures on topics like “Rodenticides” and “Breastmilk Toxicology.” And every year since she’s found a few more volunteers to add to it with other topics like “Disulfiram” or “Organic Chemistry Structures.” Today the MedTox Video Library is one of the most popular board exam prep tools in the ACMT Learning Center with 22 videos accessed by 211 users.
In 2018, Dr. Beauchamp was the leader of a committee to create Flashcards for the Board Review Course. Under her leadership, the committee developed 380 MedTox keywords and concepts which ACMT continues to make available as both an online and notecard tool for those studying for their board exams — so Dr. Beauchamp has been integral in developing not just one but two of ACMT’s most popular board prep study materials!
But of all her contributions to ACMT, one of the most notable has to be her contribution to the ACMT Tox in Ten Podcast. In collaboration with Dr. Elissa Moore, Dr. Beauchamp has developed 53 episodes in which she interviews speakers from various ACMT events in more detail about their specialty, and delivers
The ACMT Education Committee thanks Dr. Beauchamp for her service and looks forward to many more years of such high quality educational collaboration.
ACMT Activities at #NACCT2024

Thank you to everyone who joined us in Denver for the 2024 North American Congress of Clinical Toxicology (NACCT) from September 19-23, 2024! ACMT was proud to host a series of thought-provoking and dynamic sessions throughout the event.
ACMT Pre-Meeting: EntheoTox: Navigating the Psychedelic Frontier
A special thank you to the organizers, speakers, and attendees who made the ACMT Pre-Meeting on Thursday, September 19th, such a success. We would especially like to recognize Drs. Patil Armenian, Caitlin Bonney, and Benjamin Hatten for their outstanding work in organizing the symposium, EntheoTox:Navigating the Psychedelic Frontier. This event explored the fascinating and timely topic of psychedelics. With the resurgence of interest in their therapeutic potential, understanding their safety profiles has become increasingly important. The full-day symposium brought together experts from diverse fields to examine the physiological, psychological, and toxicological aspects of these compounds. The discussions shed light on the complexities of psychedelic use—from their therapeutic promise to the associated risks—ensuring we remain at the forefront of emerging trends in toxicology.
Key ACMT Events During the Main Conference:
25th Annual Clinical Pathological (CPC) Presentation Competition: The 2024 CPC was both lively and highly educational. We extend our heartfelt thanks to Dr. Jeffrey Suchard for organizing this fantastic event and to all the presenters for sharing their expertise. A special congratulations to our awardees:
- Best Case Presenter: Oyeyimika Oyekanmi, DO, Fellow, Virginia Commonwealth University
- Best Case Discussant: Damilola Idowu-Ellsworth, MD, Assistant Professor, Department of Emergency Medicine, Medical College of Wisconsin
FIT Visiting Professor Lecture: Peter R. Chai, MD MMS, and Stephanie Carreiro, MD PhD, led an insightful session on research funding, offering valuable guidance for junior toxicologists transitioning into research.
FIT Roundtable on Job Offers and Contract Negotiations: Jeffrey Brent, MD, PhD, Lewis Nelson, MD, and Christopher Hoyte, MD, shared practical negotiation strategies and career advice, helping attendees navigate the complex landscape of job opportunities in medical toxicology.
Scientific Symposium on Venomous Snake Toxinology: Sunday’s Snakes on a Plain session explored cutting-edge research on snake venom pharmacology, leaving the audience with a deeper understanding of venomous snakebite care and the challenges of studying toxins.
Practice Symposium on Non-Fatal Overdose Biosurveillance: We explored the critical role of biosurveillance data in improving overdose care and public health infrastructure. Thank you to Amy Miles, Charles McKay, MD, and Ewa King, PhD, for sharing their expertise!
We extend our deepest gratitude to everyone who made #NACCT2024 an incredible experience. A special shoutout to organizing chair, Dr. Hannah Hays!
Interactive Learning at Its Best: 2024 Virtual Courses with a Twist!

The Flipped Classroom | 2024 Board Review Course
The 2024 ACMT Board Review Course introduced an innovative approach to preparing for the biennial certification examination in Medical Toxicology administered by the American Board of Emergency Medicine (ABEM). This new format featured a dynamic blended learning structure with early access to over 30 curated on-demand lectures covering the full spectrum of medical toxicology. Participants also benefited from seven interactive cram sessions, where faculty experts highlighted key takeaways and answered questions on core topics. Study resources included 350+ flashcards, a quiz bank with 925 questions, and a mock exam to solidify understanding. With its new flipped classroom format, the course continues to empower learners through May 31, 2025 with CE included.

New Collectibles | 2024 Total Tox Course
The 2024 ACMT Total Tox Course offered a comprehensive virtual learning experience for healthcare professionals, spanning three Fridays in November. This event provided cutting-edge medical toxicology education on pharmaceuticals, substance use, emergency preparedness, and non-pharmaceutical toxicology. New continuing education credits for Pharmacists, Physicians, Physician Associates, Nurses, and Nurse Practitioners were available, expanding access to the course. Attendees also received exclusive access to the brand new Total Tox Collectibles, a set of visual stimulus cards designed to enhance clinical insights through memorable, image-based learning. The 2024 Total Tox Course is now available on-demand for purchase, with CE credits included, providing continued access to this valuable content.

ACMT Highlights Tox in Ten Podcast
Initiated in 2018, this popular podcast is now in its seventh year! ACMT members, Gillian Beauchamp, MD, and Elizabeth (Elissa) Moore, DO, deliver evidence-based medical toxicology core content and trending topics in easily digestible bites. Access the series in ACMT’s Learning Center. 9 new episodes were produced in 2024.

ACMT/AliEM Toxicology Visual Pearl Series
The Toxicology Visual Pearls series is a collaboration between ACMT and Academic Life in Emergency Medicine (ALiEM.) The pearls are open-access, expert peer-reviewed, toxicology-related visual stimuli followed by a question and discussion. The authors and editors volunteer their time and expertise to bring this well-regarded series to readers of the ALiEM blog. The series is led by Drs. Louise Kao and Howard Greller from ACMT and Dr. Kaitlin Bowers from ALiEM. There were 12 new Pearls produced in 2024. Access the full library of Pearls here.
The ANTIDOTE Institute
Program Administrators

Stephanie Carreiro, MD, FACMT
Co-PI
ToxInnovation Lab, UMass

Peter Chai, MD, FACMT
Co-PI
Chai Lab, Hardvard Medical School
Born as a collaborative effort between ACMT, the ToxInnovation Lab (UMASS), and the Chai Lab (Harvard Medical School in 2021, was granted funding from the National Institute on Drug Abuse (NIDA) through an R25 mechanism in 2023.
This program presents a unique opportunity for junior faculty members to kickstart their journey in investigative research. Participants have the opportunity to begin cultivating their own research niche, build valuable connections with peers and seasoned investigators within their field, and acquire practical knowledge encompassing key aspects of establishing a successful research program. The institute spans two years, and offers the potential for up to $25,000 in seed funding to bolster participants’ research pursuits.
The “Class of 2024” kicked off their journey at the ACMT Annual Scientific Meeting in Washington, DC in April of 2024.
Meet the ANTIDOTE Class of 2024

Matthew Dernbach, MD
Emory University
Atlanta, GA

Jacob Lebin, MD
University of Colorado School of Medicine
Aurora, CO

Simon Ostrowski, MD
University of Pittsburgh Medical Center
Pittsburgh, PA

C. James Watson, MD
Maine Medical Center
Portland, ME

Charlotte Goldfine, MD
Brigham and Women’s Hospital
Boston, Massachusetts

Jennifer Love, MD
Icahn School of Medicine at Mount Sinai
New York, NY

Michael Simpson, MD
Beth Israel Deaconess Medical Center
Boston, MA

Membership Report
2024 was a great year for ACMT membership! We celebrated a nearly 90% join rate among Fellows in Training, proving that ACMT is the place to connect for the next generation of leaders in medical toxicology.
Speaking of connections, we launched ACMT Connect, our dynamic new online community, making it easier than ever to network, collaborate, and share knowledge. September’s FIT Happy Hour at NACCT in Denver was a poisonously fun success, bringing camaraderie and conversation to the forefront. With new staff on board and more exciting opportunities in store for 2025, we can’t wait to continue strengthening the bonds that make ACMT the ultimate antidote to professional isolation! Stay tuned for more growth, engagement, and surprises ahead.


2024 New Fellows of the College
Physicians who are full members of ACMT and apply for fellow status in the College (FACMT) are evaluated by the Membership Committee. Criteria include significant involvement in the practice, research, and teaching of medical toxicology, as well as contributions in poison center management, public service, and service to the College. If these rigorous criteria are met, the Committee recommends to the Board of Directors of the College that the application be approved and the member granted the honor of recognition as a Fellow of the College (FACMT.) We are pleased to welcome the following Fellows. Please click to read full bios.

Peter Akpunonu, MD, FACMT
Dr. Peter Akpunonu earned his medical degree from the University of Toledo College of Medicine and completed his Emergency Medicine residency at the University of Kansas Hospital. He went on to complete a fellowship in Medical Toxicology at Oregon Health and Science University in Portland, Oregon. Currently, he is an associate professor of Emergency Medicine at the University of Kentucky and is the medical director of the KY Poison Control Center. He is the medical director for Toxicology and Hyperbarics at the University of Kentucky. He is also the site director for the Radiation Injury Treatment Network. In addition to his teaching and clinical responsibilities, he is interested in medical toxicology and further research opportunities to explore opioid use treatment options.

Musa Alfaifi, MD, FACMT
Dr. Musa Suliman Alfaifi is a leading figure in both emergency medicine and medical toxicology in Saudi Arabia. He currently holds the position of program director for the Saudi Board of Emergency Medicine in the Armed Forces Hospital Southern Region (AFHSR). His credentials include an MD from King Khalid University, followed by residency training in emergency medicine from National Guard Hospital, Riyadh, and a fellowship in medical toxicology from Emory University.
Dr. Alfaifi’s dedication extends beyond clinical practice. He is a pioneer in emergency medicine education, having established the first Saudi Board of Emergency Medicine in the southern region and the leader of the medical toxicology fellowship foundation group in Saudi Arabia and co-founder of the arab board of Medical Toxicology program. He is actively involved in research, with a diploma in clinical research from Harvard and numerous publications on snakebite envenomation, toxicology, and emergency medicine. His expertise is further recognized through his role as a peer reviewer in the toxicology communication journal and his authorship of the chapter on snakebite in the MENA region for a relevant medical textbook.

Nicklaus Bradehoff, MD, FACMT
Dr. Nicklaus Brandehoff is board-certified in emergency medicine, medical toxicology, and addiction medicine with a passion for herpetology and a specialization in the research and treatment of envenomations. He received his Doctorate of Medicine from the University of California San Francisco, completed residency in Emergency Medicine at UCSF-Fresno, and subsequently went on to complete a Medical Toxicology Fellowship at the Rocky Mountain Poison and Drug Center.
Dr. Brandehoff practices emergency medicine and medical toxicology in both Colorado and California. He has an appointment as Assistant Clinical Professor of Emergency Medicine at the University of Colorado School of Medicine, is faculty at the Rocky Mountain Poison and Drug Center and Denver Health. He is also the executive director of the Asclepius Snakebite Foundation, a 501(c)3 non-profit, that focuses on improving snakebite education and management in West Africa. He has won numerous awards as an educator and published multiple articles and book chapters on the subject of envenomations.

Neeraj Chhabra, MD, MSCR, FACMT
Neeraj Chhabra, MD, MSCR is an Assistant Professor of Emergency Medicine at the University of Illinois Chicago with an appointment in the AI.Health4All Center for Health Equity using Machine Learning and Artificial Intelligence. He is a consulting physician for the Illinois Poison Center, Toxikon Consortium faculty, and a volunteer physician with Cook County Health. He completed his residency in Emergency Medicine at Cook County Health and fellowship in Medical Toxicology at the Toxikon Consortium. He actively practices both Medical Toxicology and Emergency Medicine. He is an NIH-funded researcher in substance use disorders and data science.

Tharwat El Zahran, MD, FACMT
Dr. El Zahran holds the position of Assistant Professor of Clinical Emergency Medicine and medical toxicologist at the American University of Beirut Medical Center (AUBMC). She obtained her medical doctor degree from the American University of Beirut in 2011 and completed her residency in emergency medicine at AUBMC. Subsequently, she underwent a comprehensive two-year medical toxicology fellowship at Emory University and the Centers for Disease Control and Prevention (CDC). Since August 2018, she has been a full-time faculty member at AUBMC, where she serves as the Medical Director for the emergency department and Co-director of the Toxicology Service within the Department of Emergency Medicine. Additionally, she holds an adjunct assistant professor position within the Department of Medical Toxicology at Emory University in Atlanta, Georgia, USA.
Dr. Zahran is actively engaged in research endeavors, boasting over 30 peer-reviewed publications. Notably, one of her significant research studies examines tianeptine exposures reported to the national poison data system across the United States, published in MMWR. She also contributed during her second-year fellowship at CDC, along her colleagues to an outbreak investigation in Illinois, related to synthetic cannabinoid and vitamin K antagonist brodifacoum, resulting in a co authored publication in MMWR titled “Notes from the Field: Outbreak of Severe Illness Linked to the Vitamin K Antagonist Brodifacoum and Use of Synthetic Cannabinoids – Illinois”. Her diverse research interests and publications encompass studies on lead exposure in children, snake bites in Lebanon, injuries from riot control agents, pufferfish poisoning, trazodone exposures, deanxit use disorder, household product toxicity, incidents related to chemical terrorism, synthetic cannabinoids, alfa-lipoic acid toxicity, and the establishment of toxicology services in resource-limited settings, including reports on adult and pediatric toxicological exposures. Currently, she is involved in a Randomized Controlled Double-Blind Non-Inferiority Trial to evaluate the efficacy of a novel antivenom in treating snake viper envenomations in Lebanon.

Paul Gee, MD, FACMT
Paul has been working as a Medical Toxicologist associated with the New Zealand National Poisons Centre since 2008. He received his basic Toxicology training with the University of Newcastle, Australia. He is a Clinical Lecturer for the University of Otago Christchurch School of Medicine. He enjoys teaching and publishing research on pediatric poisoning, emerging drugs of abuse and trauma. He is a member of the Toxicology and Poisoning Network Australasia (TAPNA) and also a trustee for the Emergency Care Foundation (NZ).
Paul Gee is an Emergency Physician and Medical Toxicologist. He is a graduate of University of Auckland, New Zealand and completed his physician training for the Australasian College for Emergency Medicine at Christchurch Hospital, New Zealand, where he works currently. He served as Director of Emergency Medicine (Resident) Training there for nine years.

Matthew Griswold, MD, FACMT
Matthew Griswold is an assistant professor of Emergency Medicine at the University of Connecticut School of Medicine and the director of Medical Toxicology at Hartford Hospital. He received his medical doctorate from Boston University School of Medicine and completed his training in Emergency Medicine and Medical Toxicology at the University of Massachusetts. He is core faculty of the UCONN Integrated Residency on Emergency Medicine and also participates with the CT poison control center as a toxicology consultant. Dr. Griswold’s interests.
include medical education, as well as the emergence of novel psychoactive substances and overdose prevention. His research has focused on the identification of experiences of individuals who experience opioid overdose, novel strategies to ascertain fentanyl species among individuals with opioid use and identification of fentanyl analog adulterants. Dr. Griswold also leads medication education efforts in toxicology at the University of Connecticut School of Medicine.

Hallam Gugelmann, MD, FACMT
Hallam Gugelmann is a board-certified medical toxicologist and emergency medicine physician, currently working in biotech in Basel, Switzerland. Hallam completed his residency in emergency medicine at the Hospital of the University of Pennsylvania, where he served as chief resident his fourth year. This was followed by a fellowship in medical toxicology at UCSF. He subsequently worked as an emergency medicine attending at CPMC St Luke’s in San Francisco. During this time he served on and then joined the hospital’s ethics committee, and was a standing member of the pharmacy and therapeutics committee. He served as co-president of the San Francisco Emergency Physicians Association from 2018 to 2021, and was an associate director at the California Poison Control System’s San Francisco branch. In 2019, Hallam began using his toxicology training full-time at Genentech in drug development safety.
In 2021 he and his family moved to Switzerland, where he currently works as a senior medical director in a small biotechnology company in rare liver disease. His drug development experience includes rare diseases, neuroscience and psychiatry, oncology, and early- and late-phase drug development safety. Hallam is also a lecturing professor at the University of Basel in pharmacology and clinical toxicology, and provides medical-legal consultative services through the firm Park Dietz and Associates. In his free time he enjoys skiing, running, and swimming in the Rhein.

Ashley Haynes, MD, FACMT
Ashley Haynes completed training in a combined emergency medicine-internal medicine program in 2014, and a toxicology fellowship at UTSW in 2016. She has been treating substance use disorders as part of her practice since that time and is board certified in addiction medicine. She currently works for the VA at the Robert J Dole Veterans Medical Center in Wichita, KS, treating patients in a residential treatment center, a suboxone clinic, and performing bedside consults in addiction medicine and medical toxicology. She participates actively in the Addiction Toxicology Committee, as well as ACMT educational efforts. She is currently planning an addiction medicine fellowship program and is a local stakeholder for opioid response activities. She has treated exactly one snakebite since leaving Texas but countless brown recluse envenomations. She lives in Wichita, KS with her husband and 3 children, and spends her free time painting and hiking.

Diane Hindman, MD, PharmD, FACMT
Dr. Hindman is a Board-Certified Pediatrician and Medical Toxicologist, and Registered Pharmacist. She is a Clinical Assistant Professor at the University of Arizona College of Medicine Phoenix and at the University of Arizona College of Pharmacy Tucson. She works as an Attending Physician in the Emergency Department (ED) at Phoenix Children’s in Phoenix AZ, and Medical Toxicologist at the University of Arizona Poison and Drug Information Center in Tucson AZ. She completed her medical degree at Trinity School of Medicine, pediatric residency at Rainbow Babies and Children’s Hospital, and medical toxicology fellowship at Emory University and the CDC. She received her pharmacy degrees from the University of Toronto and University of Colorado. She has also completed certification in clinical translational research at the University of Arizona College of Public Health, and will be starting an Addiction Medicine Fellowship in July 2024.
Dr. Hindman wears many hats in addition to her role as an ED Attending. She serves on committees and has various other involvement with the American Academy of Pediatrics (AAP), American College of Medical Toxicology (ACMT), American Association for Emergency Psychiatry (AAEP), American Academy of Clinical Toxicology (AACT), and America’s Poison Centers (APC). She is also actively involved in numerous research and QI projects involving medication safety, appropriate prescribing, penicillin allergy delabeling, pediatric mental health disorders and boarding in the ED, and adolescent substance use. Dr. Hindman is also a provider and educator in AHLS, current Assistant Editor for the AHLS Provider Manual 6th edition, and was involved in prior updates for the AHLS Radiological Incidents and Terrorism course. In these roles she is particularly interested in countermeasures for all categories of terrorism and emerging threats, and is currently working to establish a Radiation Injury Treatment Network (RITN) site at Phoenix Children’s in Arizona.

Rana Jaffer Hamed Hussein, MBBS, CABEM, MSc-Toxicology, FACMT
Rana is an Arab Board certified Emergency medicine physician and a clinical toxicologist. She was employed at Hamad Medical Corporation-Qatar as Associate Consultant until 2021. She graduated from Aden University – Republic of Yemen in 2003. She completed Arab Board Emergency Medicine certification from HMC-Qatar in 2012. She obtained membership of Royal College of emergency medicine-UK in 2014 followed by fellowship in emergency medicine (subspecialty-medical toxicology) from HMC-Qatar in 2017. She also obtained Post graduate Diploma in Toxicology from Cardiff University- UK in 2016 and Master of Science- Medical Toxicology from PGIM-Colombo-Sri Lanka in 2022.
She was an active core faculty member with Arab Board Emergency Medicine Residency program from 2013 to 2021 which is ACGME-I accredited training center and is primarily based at Hamad General hospital- Doha, Qatar. She conducted didactic lectures, workshops and clinical simulations for Emergency Medicine residents. She was in charge of the Toxicology Tract and took special interest in delivering a diversity of workshops & simulations in this subject and conducted numerous sessions to train the residents throughout her career. She was also a
clinical lecturer at Qatar University, where she taught medical students through Interactive lectures, simulations and workshops for seven consecutive years. She functioned as a founder member of Hamad Medical Corporation’s 24*7 on-Call Toxicology services in Qatar from 2014 to 2021 where she provided round the clock care to the intoxicated patients and contributed immensely in preparing a toxicology database for the organization.
She is also a member of the TAPNA (Toxicology and Poisons Network Australasia) and MENATOX (Middle East and North African Clinical Toxicology Association). She has also presented talks on several toxicology topics in numerous prestigious international conferences in various countries across the globe. She migrated to Australia in late 2021 and is now providing her expert services to WACHS (Western Australian County Health Services). She aspires to excel as an educator of Emergency medicine & Medical Toxicology and train junior medical staff worldwide.

Hong Kim, MD, MPH, FACMT
Dr. Hong Kim, MD, MPH, FACMT is an Associate Professor of Emergency Medicine and Pharmacology at the University of Maryland School of Medicine. He graduated from University of California, San Francisco School of Medicine and completed his emergency medicine residency and medical toxicology fellowship at the New York University (NYU)/Bellevue Hospital Center and NYU/New York City Poison Control Center, respectively. Dr. Kim is affiliated with Maryland Poison Center and National Capital Poison Center and leads the Medical Toxicology Consultation Service at the University of Maryland Medical Center. Aside from spending his time with his two children, he enjoys “restoring” vintage receivers and speakers, and paddling outrigger canoes on the Potomac River in Washington D.C. during his free time.

Jeffrey Lai, MD, FACMT
Jeffrey Lai, MD, is an emergency physician and medical toxicologist at UMass Chan Medical School. He completed his undergraduate studies at the University of California, Berkeley, and medical school at the University of Pittsburgh. Following emergency medicine residency and medical toxicology fellowship at UMass, he stayed on as core faculty in the emergency medicine residency and now serves as the program director of the medical toxicology fellowship. His academic interests include medical education, medications for treatment of substance use disorders, emerging drug trends, and drug-impaired driving.

Daniel Lasoff, MD, FACMT
Daniel Lasoff, MD, serves as the Director of the UC San Diego Medical Toxicology Fellowship and is an Associate Clinical Professor of Emergency Medicine at UC San Diego. As a core faculty member for the UC San Diego Emergency Medicine Residency, he also holds the position of Assistant Director at the California Poison Control System’s San Diego site. Dr. Lasoff divides his clinical time between the Emergency Departments of UC San Diego Medical Center and El Centro Regional Medical Center, a rural community hospital in Imperial County, California. Additionally, he works as a Medical Toxicologist for both UC San Diego Medical Center and San Diego’s Rady Children’s Hospital, and is the sole Medical Toxicologist at the San Diego Veterans’ Health Administration Environmental Health Clinic. Dr. Lasoff has dedicated efforts to improve care for patients with substance use disorders within the UC San Diego Health System and the broader region, focusing on increasing access to critical life saving treatments such as buprenorphine and free naloxone in the Emergency Department. Furthermore, he promotes evidence-based treatments for these serious diseases through community education.

Kevin Maskell, MD, MSc, FACMT
Dr. Kevin Maskell, MD, MSc, is an assistant professor of military and emergency medicine at the Uniformed Services University of Health Sciences. He graduated from emergency medicine residency at Madigan Army Medical Center in 2014 and from medical toxicology fellowship at Virginia Commonwealth University in 2016. After completing his training, Dr. Maskell returned to Madigan Army Medical Center as residency core faculty and director of medical toxicology in 2016 and in 2017 started as a consulting toxicologist for the Washington Poison Center. In 2021 Kevin also earned board certification in addiction medicine. Since that year, he has also been assigned by the Army as medical director and now chief of the Tactical Medicine Readiness Division at Ft. Sam Houston, Texas, where he provides critical pre-deployment trauma training for healthcare professionals scheduled to deploy into combat zones. Dr. Maskell’s research interests include antidotal therapies, extracorporeal therapies, and envenomations.

Dan McCabe, MD, FACMT
Dan McCabe is a Clinical Associate Professor of Emergency Medicine at the University of Iowa. He is the Director of the Division of Medical Toxicology at the University of Iowa and the Medical Director of the Iowa Poison Control Center. He completed medical school at the University of Iowa, an Emergency Medicine residency at Cook County Hospital, and a Medical Toxicology fellowship at Regions Hospital/Minnesota Poison Control System. His career focus is on improving the care of poisoned patients while decreasing unnecessary resource utilization.

Nicholas Nacca, MD, FACMT
Nicholas Nacca, MD, is Director of Medical toxicology and Associate Fellowship Director for the University of Rochester Medical Center (URMC) Medical Toxicology fellowship; Clerkship Director for the Medical Student rotation in Medical Toxicology; core faculty for the URMC emergency medicine residency; Assistant professor of Emergency Medicine. He is board certified in Emergency Medicine, Medical Toxicology and Addiction Medicine. He is the organizer and host of the ACMT Grand Rounds Webinar Series.

Joshua Nogar, MD, FACMT
Dr. Nogar grew up in the High Desert of New Mexico, but has been a New Yorker for 16 years. He has been faculty in the department of Emergency Medicine and Medical Toxicology at Northwell Health/North Shore University Hospital since 2011. He has been the Medical Toxicology Fellowship director at Northwell Health since 2016, and his areas of specific interest include fellow education, metabolic uncouplers, overdose trends, and addiction medicine. He is dedicated to helping his trainees achieve their individual career goals, as well as adapting his training program to the changing scope of practice for Medical Toxicologists, as well as the needs of individual learners. Outside of work, Dr. Nogar enjoys spending time with his wife, Andrea, and their daughters, Julia and Alex. He is an avid fly-fisherman, and whiskey snob.

Aynur Sahin, MD, PhD, FACMT
Aynur Sahin is an associate professor of Emergency Medicine and Medical Toxicology consultant at the University of Health Sciences Basaksehir Cam and Sakura City Hospital, Istanbul, Turkiye. She completed her residency in Emergency Medicine at Karadeniz Technical University (KTU)in 2012, PhD degree in toxicology at Dokuz Eylül University Department of Pharmacology in 2018, and her medical toxicology fellowship at Emory University in 2019 with mentorship and great support from Prof Ziad Kazzi. She became the first and only medical toxicologist across the country as medical toxicology is not a recognized subspecialty in Turkiye. After graduation from the fellowship program, she established the first medical toxicology consultation service and inpatient unit at KTU Department of Emergency Medicine that serves the whole Black Sea Region. She organized the MENATOX 2020 conference in Istanbul, Turkiye before COVID pandemic and was selected as a board member of MENATOX. In 2021, she led a telemedicine and educational collaboration project with Emory University Division of Medical Toxicology. In 2022 she organized the first international medical toxicology conference in Trabzon with collaboration between KTU and Emory University and more than 30 experts from all over the world have participated. She was invited to establish the first medical toxicology ICU in Istanbul by Prof. Semih Korkut who is the former general director of emergency healthcare services at the Turkish Ministry of Health and with his great support in September 2022 she established the first and only Medical Toxicology ICU where more than 1000 critically ill poisoned patient have taken care of in a year by her team. On March 11, 2024, the Turkish MoH agreed to recognize medical toxicology as a subspecialty and build a national clinical training program by their official submission 1 year ago. As of July 2024, she will lead a telemedicine and international medical toxicology training program with a collaboration Project between Basaksehir Cam and Sakura City Hospital Medical Toxicology ICU and Emory University Division of Medical Toxicology. Also, she is an international member of ACMT and contributes to WHO meetings and international medical toxicology conferences. Last but not least, she is proud to be the mother of Berat Eren Sahin who is the love of her life, and biggest fan, and had to sacrifice time with his mother during her dedicated tox journey.

Joshua Shulman, MD, FACMT
Dr. Joshua Shulman, MD is the Medical Director of the Pittsburgh Poison Center. He completed his undergraduate Summa Cum Laude at the University of Pittsburgh with a Bachelor of Arts and a Bachelor of Sciences (B.A./B.S.) in History and Neuroscience. He completed his Medical Doctorate (MD) degree at the University of Pittsburgh School of Medicine in 2012. He trained as a resident physician at UPMC Medical Education in Emergency Medicine from 2012 to 2015, and as a fellow in Medical Toxicology between 2015 and 2017. He was appointed a position of Assistant Professor of Emergency Medicine and Medical Toxicology at the University of Pittsburgh School of Medicine. He also holds an appointment as an Assistant Professor of Pharmacy and Therapeutics at the University of Pittsburgh School of Pharmacy. He is a diplomate of the American Board of Emergency Medicine, American Board of Medical Toxicology, and the American Board of Preventative Medicine in Addiction Medicine. He is currently practicing in UPMC Hospitals in the fields of Emergency Medicine, Medical Toxicology and Addiction Medicine.

George Sam Wang, MD, FACMT
Dr. G. Sam Wang completed his pediatric residency and pediatric emergency medicine fellowship at Children’s Hospital Colorado in Denver, followed by his Medical Toxicology Fellowship at the Rocky Mountain Poison and Drug Safety at Denver Health Hospitals. He is currently an Associate Professor of Pediatrics at Children’s Hospital Colorado in the Section of Emergency Medicine and Medical Toxicology, and on faculty at RMPDS. He is also the Associate Medical Editor for the Pediatric Telehealth Triage Guidelines at Schmitt-Thompson Clinical Content. His main academic interests include the public health impact of cannabis use and legalization, and risk mitigation strategies for the pediatric population from the opioid epidemic.

Patrick Whiteley, MD, FACMT
Patrick Whiteley, MD, is a senior partner with Kaiser Permanente in San Jose, CA. He is a member of the KP NCAL Regional Toxicology service providing consultation services for 21 service areas and hospitals. For his local Emergency Department he is the Pediatric Emergency Care Coordinator as well as a member of the Controlled Substance Safety Clinical Workgroup. He is board certified in Emergency Medicine and Medical Toxicology. He takes special interest in educational opportunities as a faculty member for Pediatric Fundamentals of Critical Care Simulations (PFCCS) and teaching local residents and visiting medical students.
2024 ACMT Recognition Awards
We are pleased to recognize the oustanding contributions of the following Members

ACMT Career Achievement Award
Keith Burkhart, MD, FACMT
Senior Advisor for Medical Toxicology, US Department of Health and Human Services, Silver Spring, Maryland
Career Achievement Lecture: Medical Toxicology at the FDA: A Structured Public Health Career
Dr. Burkhart is the Senior Advisor for Medical Toxicology in the Division of Applied Regulatory Science in the Office of Clinical Pharmacology in the Office of Translational Science in the Center for Drug Evaluation and Research at the Food and Drug Administration (FDA). He received his medical toxicology training at the Rocky Mountain Poison Center in Denver (1988-1990). Emergency Medicine training was at the University of Cincinnati (1982-1985, Chief Resident). His Medical Degree (1982) is from the Medical College of Pennsylvania, now Drexel University. His B.S. (1978) is from Ursinus College in Biology (valedictorian). He is a Past-President and Fellow of the American College of Medical Toxicology. He is a co-editor of Critical Care Toxicology. He is the former Medical Director of the Penn State Poison Center (1990-2002) associated with an inpatient toxicology admitting service.
Research interests include antidotes and treatment of the poisoned patients. At the FDA he started a biological plausibility consult service that would analyze for potential mechanisms as supportive evidence for an emerging drug safety signal. Bioinformatic tools were evaluated and studied to support these analyses. Research has also been done to predict adverse events. He currently is the Medical Monitor for FDA sponsored clinical trials performed to inform regulatory decision making.
Outstanding Contribution to Medical Toxicology Education

Diane Calello, MD, FACMT
Rutgers New Jersey Medical School
Outstanding Contribution to Medical Toxicology Research

David Jang, MD, FACMT
University of Pennsylvania Perelman School of Medicine
Outstanding Service
to the College

Louise Kao, MD, FACMT
Indiana University School of Medicine
2024 Voluntary Service Recognition
The strength of ACMT lies in the passion, expertise, and dedication of our members. Through their volunteer service on committees, special interest sections, and education activities, these individuals play a pivotal role in advancing our mission and shaping the future of medical toxicology. The ACMT Board of Directors and staff are deeply grateful to all members who generously give their time to drive the College’s initiatives forward. We would like to extend special recognition to the following members who have gone above and beyond in their service to ACMT, making a lasting impact through their leadership, mentorship, and contributions. Your commitment inspires us all!
Peter Akpunonu, MD, FACMT
University of Kentucky
Lexington, KY
Chair, DEI Task Force
Steven Aks, DO, FACMT
Cook County Hospital
Chicago, IL
Organizer, National Journal Club
Patil Armenian, MD
University of California, San Francisco
Fresno, CA
Member, 2024 ACMT Activities at NACCT Organizing Committee
Gillian Beauchamp, MD, FACMT
Lehigh Valley Health Network/USF Morsani College of Medicine
Jefferson Health
Allentown, Pennsylvania
Editorial Board, JMT
Sarah Berg, MD
Washington University in St. Louis
St. Louis, MO
Member, 2024 ACMT Activities at NACCT Organizing Committee
Michael Beuhler, MD, FACMT
North Carolina Poison Control
Charlotte, NC
ACMT ALIEM guest editor for Visual Pearl Series
Caitlin Bonney, MD
University of New Mexico
Albuquerque, NM
Pediatric Cannabis Workgroup, Member, 2024 ACMT Activities at NACCT Organizing Committee
Heather Borek, MD
University of Virginia School of Medicine
Charlottesville, VA
In-Service
Jeffrey Brent, MD, PhD, FACMT
University of Colorado, School of Medicine
Aurora, CO
ToxIC Co-PI; Member, 2024 ACMT Activities at NACCT Organizing Committee
Daniel Brooks, MD
Center for Toxicology and Pharmacology Education & Research, College of Medicine – Phoenix
Phoenix, AZ
Articles you may have missed Editor, JMT
Keith Burkhart, MD, FACMT
US Food and Drug Administration | FDA
Silver Spring, MD
Member, #ACMT2024 Planning Committee
Michele Burns, MD, MPH
Harvard Medical Toxicology
Boston, MA
Career Achievement, Michael P. Spadafora Medical Toxicology Travel Award Reviewer
Diane Calello, MD, FACMT
Rutgers New Jersey Medical School, New Jersey Poison Information and Education System
Newark, NJ
ACMT ALIEM guest editor for visual pearl series, Chair, Education Committee, Pediatric Workgroup
Shaun Carstairs, MD, FACMT
Scripps Healthcare San Diego/Rady Children’s Hospital San Diego
San Diego, CA
2023 ASM Planning Committee
Jennifer Carey, MD
UMass Chan Medical School
Worcester, MA
ANTIDOTE Institute
Stephanie Carreiro, MD, PhD
UMass Chan Medical School
Worcester, MA
ANTIDOTE Institute-PI, Research Committee
Peter Chai, MD
Brigham and Women’s Hospital
Boston, MA
ANTIDOTE Institute Co-PI; Research Committee
Nathan Charlton, MD
University of Virginia
Charlottesville, VA
In-Service
Michael Chary, MD, PhD
Weill Cornell Medicine Peekskil, NY
Chair, #ACMT2024 Abstract Review Committee
James Chenoweth, MD, MAS
University of California, Davis
Sacramento, CA
Position Statements
John Downs, MD, MPH, DABT, FACP, FACOEM
VCU Health
Midlothian, VA
Chair, Occupational Environmental Section
Suzanne Doyon, MD
University of Connecticut
Farmington, CT
Pediatric Cannabis Workgroup
Leslie R. Dye, MD, FACMT
Wright State University Boonshoft School of Medicine
Waynesville, OH
Member, #ACMT2024 Symposium Planning Committee, Chair-Addiction Toxicology Committee
Brenna Farmer, MD, MBA, MS
NYP-Lower Manhattan Hospital Emergency Department
Weill Cornell Medicine
New York, NY
Chair, Medication Management Section
Fiona Garlich, MD, FACMT
Los Angeles General Medical Center
Santa Monica, CA
Chair, Women-In-Toxicology Section
Charlotte Goldfine, MD
Brigham and Women’s Hospital
Boston, MA
Co-Chair, #ACMT2024 Abstract Review Committee
Rose Goldman, MD, MPH
Cambridge Health Alliance
Harvard University
Cambridge, MA
ACMT ALIEM guest editor for visual pearl series
Andis Graudins, MB BS, PhD, FACMT
Monash Clinical Toxicology Unit, Monash Health Dandenong Hospital Campus, Dandenong, Victoria, Australia
Clinical Sciences at Monash Health, Monash University, Monash Medical Centre Campus, Clayton, Victoria, Australia
Brighton, Austrailia
Case Reports Editor, JMT
Spencer Greene, MD, MS, FACMT
University of Houston Tilman J. Fertitta Family College of Medicine
Kingwood, TX
Chair, Toxinology Section
Howard Greller, MD
Rutgers New Jersey Medical School
Newark, NJ
JMT Deputy Editor
Christina Hantsch, MD, FACMT
US Food and Drug Administration | FDA
Chicago, IL
Chair, 2024 Total Tox Course Organizing Committee; Organizer, EAPCCT Transatlantic Toxicology Talk
Jeremy Hardin, MD
University of California, San Diego
San Diego, CA
Pediatric Cannabis Workgroup
Benjamin Hatten, MD, MPH
University of Colorado School of Medicine
Denver, CO
Member, 2024 ACMT Activities at NACCT Organizing Committee
Ashley Haynes, MD
Veterans Health Administration
Andover, KS
Member, #ACMT2024 Symposium Planning Committee; Member, 2024 Total Tox Course Organizing Committee, Addiction Toxicology Committee
Hannah Hays, MD, FACMT
Nationwide Children’s Hospital, Central Ohio Poison Center
Ohio State University College of Medicine
Columbus, OH
Chair, 2024 ACMT Activities at NACCT Organizing Committee, Pediatric Cannabis Workgroup
Michelle Hieger, DO
Wellspan Health York Hospital
Red Lion, PA
Member, 2024 Total Tox Course Organizing Committee
Diane Hindman, MD, PharmD, FACMT
Biomedical Advanced Research and Development Authority (BARDA)
Phoenix, AZ
Pediatric Cannabis Workgroup
Michael Hodgman, MD
Upstate New York Poison Center
Syracuse, NY
Reviews Editor, JMT
David Jang, MD, FACMT
Penn Medicine
Philadelphia, PA
Chair, MTF Shark Tank Research Forums
Kelly Johnson-Arbor, MD
MedStar Georgetown University Hospital
Washington, DC
Member, #ACMT2024 Planning Committee
Dana Jorgenson, DO
University of Iowa Hospitals & Clinics
Iowa City, IA
2024 ACMT Total Tox Course
Andrew King, MD
Michigan Poison and Drug Information Center
Detroit, MI
Member, 2024 ACMT Activities at NACCT Organizing Committee; Member, 2024 Total Tox Course Organizing Committee
Bryan Judge, MD, FACMT
Michigan State University
Grand Rapids, MI
ACMT ALIEM guest editor for Toxicology Visual Pearl series
Shana Kusin, MD
Oregon Health & Science University
Portland, OR
Chair, #ACMT2024 Abstract Review Mentorship Program
Eric Lavonas, MD
Denver Health
Denver, CO
Editorial Board, JMT
Vincent Lee, MD
Northwell Health
Astoria, NY
Member, 2024 Board Review Course Planning Committee
Jerrold Leikin, MD, FACMT
University of Illinois Chicago
Chicago, IL
ACMT ALIEM guest editor for visual pearl series
Michael Levine, MD, FACMT
University of California, Los Angeles
Los Angeles, CA
Member, 2024 Board Review Course Planning Committee
Erica Liebelt, MD
University of Arkansas for Medical Sciences
Little Rock, AR
President Medical Toxicology Foundation; Pediatric Cannabis Workgroup
S. Eliza Lockwood, MD, FACMT
Bayer Crop Science
Chesterfield, MO
Organizer, Medical Toxicology in Industry Webinar Series
Ryan Marino, MD
Case Western Reserve University School of Medicine
Cleveland, OH
Addiction Toxicology Committee
Kevin Maskell, MD, MSc, FACMT
US Army Office of the Surgeon General
McLean, VA
Member, 2024 Total Tox Course Organizing Committee
Howard McKinney Jr., PharmD
American Board of Applied Toxicology & North American Society of Toxinology
Auburn, CA
Member, 2024 Total Tox Course Organizing Committee
Christopher Meaden, MD, FACMT
Rutgers New Jersey Medical School
Newark, NJ
Chair, 2024 Board Review Course Planning Committee
Avery Michienzi, DO
University of Virginia Health
Charlottesville, VA
In-Service
Elizabeth Moore, DO
Weill Cornell Medicine
New York, NY
Tox-in-Ten ACMT Highlights Podcast
Michael Moss, MD
Utah Poison Control Center
Salt Lake City, UT
Pediatric Cannabis Workgroup
Lauren Murphy, MD
Temple University
Philadelphia, PA
In-Service
Mark Mycyk, MD, FACMT
Cook County Health
Chicago, IL
Research Committee
Nicholas Nacca, MD, FACMT
University of Rochester Medical Center
Rochester, NY
Organizer, National Grand Rounds
Kris Nanagas, MD, FACMT
Indiana University School of Medicine
Indianapolis, IN
ACMT ALIEM guest editor for visual pearl series
Lewis S. Nelson, MD, MBA, MS
Schmidt College of Medicine at Florida Atlantic University
Boca Raton, FL
Organizer, National Case Conference, Pediatric Cannabis Workgroup
Natalie Neumann, MD
University of Colorado School of Medicine
Denver, CO
Editorial Board, JMT
Katherine O’Donnell, MD
Boston Childrens Hospital
Boston, MA
Editorial Board, JMT
Simon Ostrowski, MD
University of Pittsburgh
Pittsburgh, PA
Pediatric Cannabis Workgroup
Mehruba Parris, MD
Rutgers New Jersey Medical School
Newark, NJ
Position Statements
Leslie Pepin, MD
Hennepin County Medical Center and Minnesota Regional Poison Center
Minneapolis, MN
Pediatric Cannabis Workgroup
Jeanmarie Perrone, MD
University of Pennsylvania
Philadelphia, PA
Medication Safety Editor, JMT
Renee Petzel Gimbar, PharmD
College of Pharmacy, University of Illinois
Chicago, IL
Member, 2024 Total Tox Course Organizing Committee
Robert “Cole” Pueringer, MD, FACMT
Essentia Health
Duluth, MN
Member, #ACMT2024 Symposium Planning Committee, Addiction Toxicology Committee
Josh Radke, MD
University of Iowa Health Care
Iowa City, IA
ACMT ALIEM guest editor for visual pearl series
Michelle Ruha, MD, FACMT
Banner – University Medical Center
Phoenix, AZ
ACMT ALIEM guest editor for visual pearl series
Brian Schultz, MD
Johns Hopkins Children’s Center
Baltimore, MD
Pediatric Cannabis Workgroup
Silas Smith, MD
NYU/NYC Poison Center
New York City, NY
Pediatric Cannabis Workgroup
Meghan Spyres, MD
The University of Arizona College of Medicine
Phoenix, AZ
Editorial Board, JMT
Priya Srihari, MD
Keck Medicine of USC
Los Angeles, CA
Chair, Women-In-Toxicology Section
Mark Su, MD, MPH
New York City Poison Center
New York, NY
Pediatric Cannabis Workgroup
Jeffrey Suchard, MD, FACMT
UC Irvine School of Medicine
Irvine, CA
Member, 2024 ACMT Activities at NACCT Organizing Committee
Milton Tenenbein, MD
University of Manitoba, Winnipeg
Winnipeg, Canada
Editorial Board, JMT
Josef G. Thundiyil, MD, MPH
Orlando Health, Department of Emergency Medicine
Orlando, FL
ACMT ALIEM guest editor for visual pearl series
Michael S. Toce, MD, MS, FACMT
Attending, Pediatric Emergency Medicine/Medical Toxiology Boston Children’s Hospital; Assistant Professor of Pediatrics and Emergency Medicine, Harvard Medical School
Torrington, CT
Chair ASM abstract review
Joshua Trebach, MD
University of Iowa Hospitals & Clinics
Iowa City, IA
Member, 2024 Board Review Course Planning Committee
Marit Tweet, MD
Southern Illinois University School of Medicine
Springfield, IL
Pediatric Cannabis Workgroup
Steven J. Walsh, MD, FACMT
Jefferson Health
Philadelphia, PA
In-Service
Richard Wang, DO, FACMT
National Center for Environmental Health
Atlanta, GA
Editorial Board, JMT
Richard Wang, DO, FACMT
National Center for Environmental Health
Atlanta, GA
Editorial Board, JMT
Sam Wang, MD
University of Colorado School of Medicine
Denver, CO
Pediatric Cannabis Workgroup
Ashley Webb, MSc, PharmD
Kentucky Poison Control Center
Louisville, KY
Editorial Board, JMT
Stephanie Weiss, MD, PhD
National Institute on Drug Abuse
Baltimore, MD
Member, 2024 ACMT Activities at NACCT Organizing Committee; Member, #ACMT2024 Planning Committee
Timothy Wiegand, MD, FACMT
University of Rochester Medical Center
Rochester, NY
Organizer, Addiction Toxicology Case Conference
Anselm Wong, MBBS, PhD, FACMT
Austin Hospital
Victoria, Australia
ACMT ALIEM guest editor for visual pearl series
Stephen P. Wood, DMSc, ACNP
Northeastern University / MGB Faulker Hospital/Boston Medical Center
Boston, MA
Member, 2024 ACMT Activities at NACCT Organizing Committee
David Wood, MD
Guy’s and St Thomas’ NHS Foundation Trust
London, UK
Editorial Board, JMT
Michael Yeh, MD
National Center for Environmental Health
Atlanta, GA
Chair, Government Section
Luke Yip, MD, FACMT
Denver Health
Denver, CO
Member, 2024 ACMT Activities at NACCT Organizing Committee
Committees and Sections
ACMT offers members meaningful opportunities to shape the future of medical toxicology through active participation in our committees and sections. From crafting educational content to creating spaces for professional connection, these groups play a vital role in advancing ACMT’s mission and fostering a strong, engaged community. We are grateful for the dedication of our committee and section chairs, as well as the members who generously contribute their time and expertise.
In 2024, our committees and sections achieved several exciting milestones. Here are just some of the highlights:
The Women in Tox Section hosted a successful meetup at NACCT, bringing members together for thoughtful discussion on goals and career milestones.
Diversity, Equity, and Inclusion (DEI) Committee is developing a new position statement to guide ACMT’s DEI efforts on unconcious bias when seeing patients.
Recent Graduates Section collaborated with EMRA’s Toxicology Section to present a webinar in January 2025, focused on building professional connections and navigating early-career challenges.
Residents & Medical Students Section shared practical advice with trainees through a December 2024 webinar on Time Management, helping future toxicologists balance clinical responsibilities and personal growth.
Fellows-in-Training (MFITA) offered invaluable insights through a November 2024 webinar on Interview Tips & Tricks and hosted a successful (and fun!) meetup at NACCT to connect current and future leaders in the field. The International Section is developing a plan to stay engaged with the World Federation of Toxicology Organizations (WFTO), reinforcing ACMT’s commitment to global collaboration. These accomplishments are just the beginning! Our committees and sections provide a pathway for members to connect, share expertise, and drive meaningful change. Interested in getting involved? Whether you’re passionate about education, advocacy, or global outreach, ACMT has a place for you to make a difference. Reach out to learn how you can join one of our vibrant committees or sections and leave your mark on the field of medical toxicology.
Addiction Toxicology Committee
Chair: Leslie R. Dye, MD, FACMT
Staff Liaison: Amanda M. Sutphin, BSHCA, EMT-P
Vision: All medical toxicologists will be provided with the opportunity to develop an advanced working knowledge of the evaluation and treatment of patients with substance use disorders and be proficient and capable of practicing addiction toxicology independently. Medical toxicologists will have opportunities to contribute to and expand the knowledge of the addiction medicine community inside and outside of ACMT in the discipline of addiction toxicology.
Mission: Ensure that medical toxicologists remain current on the evolution of ideas and management of addiction-related conditions.
Provide medical toxicologists with opportunities to contribute and share their unique addiction toxicology expertise with other addiction experts inside and outside of ACMT
Goals:
- Provide opportunities for medical toxicologists to remain current in the evaluation and treatment of patients with addiction-related diseases and substance use disorders
- Support medical toxicologists choosing to sit for the American Board of Preventive Medicine Addiction Medicine Board Exam via the Practice Pathway
- Advocate for the care of all medical toxicology patients with conditions related to substance use, including substance use disorders
- Provide a resource of current knowledge and practices in Addiction Toxicology for all members of ACMT
Education Committee
Chair: Diane Calello, MD, FACMT
Staff Liaison: Adrienne Dunavin
This committee determines the educational needs of the membership (as identified through needs assessments and feasibility studies) and identify or develop resources and delivery modalities to address those needs. They also assess current educational offerings and partnerships and monitor the ongoing effectiveness of all educational activities.
Goals:
- Determine educational needs of the membership
- Provide guidance and help develop content for conferences, webinars, and other course offerings
- Identify or develop resources and delivery modalities
- Assess current educational offerings and partnerships
Membership Committee
Chair: Evan Schwarz, MD
Staff Liaison: Rebecca Weinstein
This committee determines the eligibility of applicants for active membership and fellowship, represents and monitors the needs of the membership, recommends policies, procedures, and initiatives to assure a growing and vital membership organization and organizes the annual FACMT Reception.
Goals
- Recommends policies, procedures, and initiatives to assure a growing and vital membership
- Determines eligibility of applicants for active membership and fellowship by reviewing credentials of all applicants
- Increase awareness of medical toxicology to medical students and residents (family medicine, internal medicine, pediatrics as well as emergency medicine) through promoting existing conferences / webinars and targeted outreach
- Develop and sustain diversity, equity, and inclusion focus throughout ACMT
Clinical Practice & Position Statements Committee
Chair: Andrew Stolbach, MD, FACMT
Staff Liaison: Lucinda Gonzales
This committee is responsible for developing position statements, guidelines, and commentary for ACMT. The committee reviews existing position statements and recommends revising, reaffirming, or retiring them. The committee may explore, participate, and draft position statements, guidelines and commentary with other organizations when appropriate.
Goals
- Develops position statements, practice statements, guidelines, and commentary for ACMT and makes a recommendation to the board for adoption
- Reviews existing position statements and practice statements and makes a recommendation for revision, reaffirmation, or retirement.
Research Committee
Chair: Maryann Amirshahi, MD, FACMT
Staff Liaison: Rebecca Weinstein
This committee is responsible for reviewing applications and organizing the selection process for various research grants. The Research Committee also organizes the research poster session and assists and provides guidance with the Fellows-in-Training Research Forum at our Annual Scientific Meeting.
Overview
- Develop opportunities for originial research presentations
- Organize the Fellow-in-Training Research Forum
- Provide oversight and scientific review of ToxIC studies and ACMT surveys
- Provide oversight and scientific review of the Medical Toxicology Foundation Research Awards
- Provide oversight to ASM Abstract Review
- Organize ASM Abstract Review
Government and Public Health Section
Chair: Michael Yeh
Staff Liaison: Dana Karshenas
The Government Section works to develop and conduct activities that promote medical toxicology in those working in, as well as those interested in government. These activities shall relate to ACMT, that is the American College of Medical Toxicology, and shall fulfill the following objectives: to serve as the forum for members interested in government to interact; to stimulate awareness about government; to identify areas that can benefit from medical toxicology input in the government; to identify areas worthy of further pursuits that might contribute to these ends within the membership; and to act as a resource to the ACMT with reference to the government.
Industry Section
Chair: S. Eliza Lockwood, MD, FACMT
Staff Liaison: Mimi Bajagich
The aim of this section is to increase awareness of the critical role of industry in bringing innovative ideas to market. Industry is in a unique position to bridge cutting edge research from academia and the regulatory requirements set by governmental agencies. This is increasingly important as government funding for research is declining. Our second goal is to increase the dialogue between academia and industry in order to maintain transparent and ethical channels of communication. Industry section members will actively engage with ACMT and other academic institutions to promote the work of faculty and fellows.
International Section
Chair: Ziad Kazzi, MD, FACMT
Staff Liaison: Rebecca Weinstein
The International Section will provide a platform for ACMT members with interest and involvement in international activities to share knowledge, collaborate and network in a professional setting.
Legal and Consultative Section
Chair: Brent Furbee, MD, FACMT
Staff Liaison: Rebecca Weinstein
The Legal and Consultative Section will provide a forum for those members interested or involved in medico-legal aspects of toxicology. The section meetings will be used to discuss principles and controversies that accompany the clinical and scientific evaluation of toxicology-related claims and will focus on issues common to the medical-legal review of charts, assessment of literature, written reports, deposition, and trial.
Medication Management Section
Chair: Brenna Farmer, MD, FACMT
Staff Liaison: Rebecca Weinstein
This section works to promote appropriate medication use, discusses issues related to formulary process and decisions, medication safety, prevention of adverse events, adverse reactions, drug shortages, and pharmacy integration across large healthcare systems (e.g., off-label use, restricted use of pharmaceuticals). This section is responsible for aiding the Clinical Practice and Position Statements Committee in developing and updating relevant position statements.
Military Section
Chair: Shaun Carstairs, MD, FACMT
Staff Liaison: Rebecca Weinstein
The ACMT Military section endeavors to connect medical toxicologists working in the various branches of the military (Army, Navy, and Air Force) and to advance the utilization of the unique skill set of medical toxicologists within the military. Section meetings will aim to promote research collaboration among military medical toxicologists and to discuss toxicology-related issues of direct importance to the conduct of military operations, such as nuclear/biological/chemical weapons training and the use of antivenoms in areas of military operations.
Occupational and Environmental Health Section
Chair: John Downs, MD
Staff Liaison: Dana Karshenas
Pediatric Section
Chair: Shan Yin, MD, FACMT
Staff Liaison: Rebecca Weinstein
The purpose of this section is to provide ACMT members a platform to communicate about common interests to those who have an interest in medical toxicology as it pertains to children. This section will focus on continuing to bridge the gap between pediatrics and medical toxicology including fostering awareness about careers in medical toxicology for those with primary training in pediatrics, creating additional opportunities for those with a joint interest in pediatrics and medical toxicology, and enhancing the awareness of others about our highly specialized members. The Pediatric section will serve as the forum for members who have a specific interest in the care of children and to identify strategic areas of interest for those with both pediatric and medical toxicology training, In addition interested section members could assist the college on consultation matters pertaining to toxicological issues in children.
Recent Graduate Section
Chair: Kavita Babu, MD, FACMT, FACEP
Staff Liaison: Rebecca Weinstein
This section is intended for anyone who has completed a medical toxicology fellowship in the last 8 years. The Recent Graduate section serves to foster collaboration between members as well as provide networking and resources for junior toxicologists just starting their careers.
Resident and Medical Student Section
Chair: Kathryn T. Kopec, DO, FACMT
Staff Liaison: Rebecca Weinstein
This section aims to engage residents and medical students in the field of medical toxicology. This section provides resources and guidance on entering and thriving within the field of medical toxicology. This section hopes to assist trainees with participating in toxicology research, finding clinical opportunities, pursuing a toxicology fellowship, exploring careers within the field, and finding mentors.
Toxinology Section
Co-Chairs: Michelle Ruha, MD, FACMT
Spencer Greene, MD
Staff Liaison: Mari Costantini
The ACMT Toxinology Section brings together ACMT members with focused clinical or research
expertise in venoms and poisons from animals, plants, and mushrooms. The Section aims to
leverage members’ specific expertise in areas within toxinology, in order to educate and
provide resources for medical professionals to improve diagnosis, management, and outcomes
for patients.
Objectives
- Establish a contact list of members with expertise in the following areas, who will be
available for consult with medical professionals or poison centers encountering an unusual
toxinology case: North American snakes, non-native snakes, arthropods, hymenoptera,
lizards, marine venoms and toxins, plants and mushrooms. - Develop a repository of important toxinology literature and resources on ACMT.net.
- Develop an interactive platform on ACMT.net where members can post and discuss new
toxinology literature and share challenging cases. - Connect and collaborate with Toxinology organizations such as the North American Society
of Toxinology to expand educational opportunities for ACMT members. - Provide guidance to ToxIC leadership regarding potential ToxIC subregistry research and
grant applications.
Women in Tox Section
Co-Chairs: Caitlin Bonney, MD, FACMT, Fiona Garlich, MD, FACMT, Elizabeth Moore, DO, and Priya Srihari, MD
Staff Liaison: Rebecca Weinstein
This section formed in 2017 to promote awareness of gender inequality and its implications for women and men in medicine. Our goal is to address these inequalities through various measures including mentorship, promotion, and regular discussions. The group is inclusive of both women and men, and all are ACMT members are welcome.
We currently use Slack (Team URL: womenintox.slack.com) as a forum to foster discussion and provide networking and mentoring opportunities. For access, email Elissa Moore at moore.elissa@gmail.com.
Follow Us! @WomenInTox
Practice Section
Chairs: Christina Hantsch, MD, FACMT
Staff Liaison: Dana Karshenas
Description coming soon.
In Memoriam (To be updated)
Christopher Linden, MD, FACMT
September 30, 1952 — August 26, 2023

The ACMT Community mourns the loss of Dr. Christopher Linden, renowned for his groundbreaking contributions in the fields of emergency medicine and medical toxicology, who passed away on August 26, 2023. His extraordinary life and remarkable achievements have left an indelible mark on the medical community, his peers, colleagues, and students.
Outside the realm of medicine, Dr. Linden was a joy. He loved spending time with his colleagues, discussing dram shop laws and Daubert proceedings over dinner or late-night poker sessions. He made everyone feel like they had a seat at his table and welcomed us all to share in his knowledge and experiences. His brilliance, patience, and mastery of medicine changed all of us lucky enough to know him well.

Toxicology Investigators Consortium (ToxIC)
(Needs update)
The Toxicology Investigators Consortium (ToxIC) is ACMT’s multicenter toxico-surveillance network that identifies new and emerging drugs of abuse, adverse effects of new medications in the post-marketing phase, and emerging toxicological threats.
In 2023, ToxIC received funding to support six major projects. Fourteen papers and 47 abstracts were published in 2023. ToxIC expanded its staff to include two new people to support its expanding programs. Alyssa Falise, PhD, MSPH is our new Research Associate. She is a public health epidemiologist and biostatistician. We hope that she will increase our capacity for obtaining grant support for ToxIC and will improve research efforts for investigators. Amanda Sutphin, BSHCA, EMT-P is our new Clinical Research Coordinator supporting several new ToxIC projects.

Core Registry
The ToxIC Core Registry is our largest project with detailed clinical information on patients seen by medical toxicologists across the world. With over 36 sites contributing to the Core Registry, over 103,000 cases have been accrued in the last 14 years. The Core Registry is supported, in part, by the Center for Disease Control and Prevention (CDC) and the Food and Drug Administration (FDA).

RENDOR Project
The Real-world Examination of Naloxone for Drug Overdose Reversal (RENDOR) project examines the real-world administration of opioid antagonists by community members, fire and police departments, and emergency medical services (EMS) personnel. The RENDOR project launched in San Francisco, CA; Detroit, MI; Portland, OR; and Pittsburgh, PA. In 2023, this initiative was made possible through funding awarded to ToxIC by the FDA Broad Agency Announcement (BAA). Read press release.

Fentalog Project
The ToxIC Fentanyl Analog (Fentalog) Project was initiated in 2020 and is funded by the National Institute on Drug Abuse (NIDA). Data has been collected on over 1,800 cases of suspected opioid overdose. Under the leadership of Alex Manini, MD, from the Icahn School of Medicine, ToxIC serves as the data coordinating center collecting information from 10 sites across the country. The Center for Forensic Sciences, Research and Education (CFSRE) performs analysis on each biological specimen via liquid chromatography quadrupole time of-flight mass spectrometry (LC-QTOF-MS) that test for more than 1,200 drugs including a vast majority of novel psychoactive substances and metabolites. Over the last year, this study has been featured on the CDC website as one of their two nonfatal overdose dashboards.

DOTS Project
The Drug Overdose Toxico-Surveillance (DOTS) Reporting Program identifies cases of suspected opioid and stimulant overdose, and incorporates a patient interview, chart review, and comprehensive qualitative and quantitative laboratory testing for novel psychoactive drugs. Starting in 2022, DOTS has over 600 cases to date from 17 participating sites across the United States.
ACMT/ToxIC Awarded a One-Year Patient Engagement Award from the Patient Centered
Outcomes Research Institute (PCORI) — NEEDS UPDATE. Do we have other news we want to add for 2024?
This project brought together medical toxicologists, community stakeholders, and patients with lived experience of intentional/purposeful overdoses to develop partnerships and research ideas. The project team alongside participating medical toxicologists learned more about each patients’ experience during their post-overdose care and the group created a list of research priorities to ultimately improve the care and long-term recovery of patients who experience an intentional overdose. Meetings consisted of 9 patient experts, 3 community stakeholders (representing national organizations including the Addiction Policy Forum and the American Foundation for Suicide Prevention), and several medical toxicology researchers. In addition to the list of research priorities, the team also developed a patient engagement strategy guide that can be disseminated to researchers who are interested in creating partnerships with patient experts to conduct patient-centered outcomes research on intentional overdoses.
Thank you, 2023 ToxIC Investigators! (Needs update)
ACMT and ToxIC would like to recognize the following ACMT members who have contributed to the ToxIC Registry in 2023.
Michael Abesamis
Peter Akpunonu
Timothy Albertson
Adam Algren
Afra Alsuwaidi
Alexandra Amaducci
John Archer
Yaqdhan Al Atbil
Sukhshant Atti
Robert Avera
Kavita Babu
Alexander Baer
Fatma Al Balushi
Kevin Baumgartner
Gillian Beauchamp
Vik Bebarta
Melisa Lai Becker
Noah Berland
David Betting
Michael Beuhler
Steven Bird
Anna Bloom
Mathew Blundell
Evan Bradley
Nicklaus Brandehoff
Jeffrey Brent
Daniel Brooks
Jennie Buchanan
Michele Burns
Diane Calello
Vincent Calleo
Michel Camarena
Joshua Canning
Dazhe Cao
Joseph Carpenter
Stephanie Carreiro
Emma Cassidy
Rachel Castelli
Trevor Cerbini
Edward Cetaruk
Nathan Charlton
Michael Chary
Richard Chen
James Chenoweth
Samy Chettat
Michael Christian
Richard Church
Joseph Clemons
Daniel Colby
Ryan Cole
Albert Conicella
Matthew Cook
Matthew Correia
Christopher Counts
Colleen Cowdery
Robert Cox
Amelia Curtis
Paul Dargan
John Delbianco
Jason Devgun
Frank Dicker
Chistopher Dion
Bernard Eisenga
Jason Elzinga
Lindsey Epperson
Henry Farrar
Chris Feng
Derek Fikse
Ari Filip
Allison Font
Jonathan Ford
Carolyn Fox
Keith French
Aaron Frey
Kira Galeano
Hayley Gartner
Timlin Glaser
David Goldberger
Will Goodrich
Kimberlie Graeme
Powell Graham
Spencer Greene
Howard Greller
Matthew Griswold
Veronica Groff
Mayank Gupta
Stacey Hail
Thao-Phuong Christy Hallett
Laurie Halmo
Alexandra Hamelin
Riley Hartmann
Benjamin Hatten
Marissa Hauptman
Kennon Heard
Will Heise
Robert Hendrickson
Reynaldo Hernandez
Michelle Hieger
Jacqueline Hiob
Ruby Hoang
Michael Hodgman
Christopher Holstege
Jason Hoppe
Keahi Horowitz
Zane Horowitz
Christopher Hoyte
Adrienne Hughes
Laura Hunter
Katherine Hurlbut
Janetta Iwanicki
Sundip Jagpal
Laura James
LilyAnne Jewett
Brett Johnson
David Johnson
Chase Jones
Seth Jones
Bryan Judge
Min Kang
Louise Kao
Sabrina Kaplan
Kenneth Katz
Ziad Kazzi
Mike Keenan
Abigail Kerns
Michael Khoury
Emily Kiernan
Ronald Kirschner
Kurt Kleinschmidt
Natalie Ebeling Koning
Andrew Koons
Michael Kosnett
Michael Kowalski
James Krueger
Jessica Krueger
Shana Kusin
Jeffrey Lai
Dayne Laskey
Rebecca Latch
Ophir Lavon
Eric Lavonas
Alex Lazar
Jacob Lebin
Michael Levine
Brian Lewis
Erica Liebelt
Rafael Lima
David Liss
Annette Lopez
Scott Lucyk
Forrest Mahony
Greg Makar
Kevan Mamdouhi
Michael Marlin
Stacy Marshall
Kelsey Martin
Danae Massengill
Nik Matsler
Connor Mcdonald
Charles McElyea
Eric McGillis
Christopher Meaden
Avery Michienzi
Christopher Mitchell
Nadia Mohammad
Andrew Monte
Elizabeth Catherine Moore
Pamela Moore
Brent Morgan
Michael Mullins
Karen Muschler
Agnesa Mustafa
Kristine Nanagas
Lewis Nelson
Natalie Neumann
Kim-Long Nguyen
Tuyet-anh Nguyen
Matthew Noble
Supa Niruntarai
Ayrn O’Connor
Katherine O’Donnell
Devin Odom
Simon Ostrowski
Rittirak Othong
Jenna Otter
Daniel Overbeek
Serah Oyewole
Mehruba Parris
Lesley Pepin
Todd Phillips
Timothy Pollak
Shelby Randall
Rama Rao
Shanaz Rashid
Tony Rianprakaisang
Marc Rigatti
Morgan Riggan
Bradley Riley
Daniel Rivera
Brett Roth
Anne-Michelle Ruha
William Rushton
Nicholas Sajko
Steven Salhanick
Cynthia Santos
Nishita Saraiya
David Schaffer
Pieter Scheerlinck
Scott Schmalzried
Evan Schwarz
Michael Semple
Kerollos Shaker
Elizabeth Shanahan
Kapil Sharma
Sophia Sheikh
Eddie Shin
Reeves Simmons
Mark Simon
Michael Simpson
Serge Emile Simpson
Miya Smith
Jerry Snow
Arjumand Sohaila
Dawn Sollee
Tony Spadaro
Hannah Spungen
Meghan Spyres
Jennifer Stephani
Fermin Suarez
Suad Al Sulaimahi
Lachie Sund
Ryan Surmaitis
Courtney Temple
John Thompson
Stephen Thornton
Christopher Threapleton
Michael Toce
Andrew Troger
David Vearrier
Steven Walsh
Sam Wang
George Warpinski
Mitchell Waters
Mary Wermuth
Jim Whitledge
Tyler Willing
Brian Wolk
David Wood
Mark Yarema
Tim Yeung
Luke Yip
Amy Young
Jennifer Zacharia
Matthew Zuckerman

Journal of Medical Toxicology
As the official journal of ACMT, the Journal of Medical Toxicology (JMT) is managed by an editorial board of 29 internationally recognized experts and thought leaders in medical toxicology who are dedicated to publishing cutting edge scientific research to advance the science and practice of medical toxicology.
JMT articles generate considerable interest among scholars and media outlets worldwide. In 2024 JMT celebrated its 20 th year of continuous publishing. JMT article highlights in 2024 include commentaries from all past and present editors-in-chief on the evolution of the journal, the Annual ToxIC Report and commentary from ToxIC leadership reflecting on the remarkable growth of that research consortium over the last 15 years, ACMT’s Research Agenda 2024-2030, and several cutting edge studies that have been cited by other researchers, policymakers, and clinicians.
In 2024 JMT recruited 3 new editors to join the editorial board. Joseph Carpenter, MD from Emory, Bryan Hayes, PharmD from Harvard Medical School, and Jennifer Love from Icahn Mt. Sinai officially begin their service at JMT in January 2025. Our 2024-25 FIT Editors are Matthew Dernbach, MD from Emory and Timlin Glaser from Banner Phoenix.
In appreciation to the volunteer experts who have gone above and beyond with high quality manuscript reviews in 2024, 20% of JMT’s peer reviewers were again recognized as “Distinguished Reviewers” by the editorial board of the journal. The generous work by our expert reviewers to evaluate 300+ submissions in 2024 make the science and practice of medical toxicology better.
This journal is committed to upholding the integrity of the scientific record and sustaining the trust of all readers. As a member of the Committee on Publication Ethics (COPE), the journal follows COPE guidelines and encourages authors and reviewers to do so

“The awe-inspiring science published in JMT continues to elevate the entire speciality of medical toxicology.”
-Mark. B. Mycyk MD, FACMT
Editor-in-Chief, Journal of Medical Toxicology
Journal of Medical Toxicology Editorial Board
Editor-in-Chief : Mark Mycyk, MD, FACMT
Deputy Editor: Howard Greller, MD, FACMT
Editorial Board:
Maryann Amirshahi, PharmD, MD, MPH, FACMT
Stephanie Carreiro, MD
Eric Lavonas, MD, FACMT
Michael Levine, MD, FACMT
Natalie Neumann, MD
Katherine O’Donnell, MD
Meghan Spyres, MD, FACMT
Milton Tenenbein, MD, FACMT
Richard Y. Wang, MD, FACMT
Ashley Webb, MSc, PharmD
Anselm Wong, MBBS DipTox, PhD, FACMT
David M. Wood, BSc, MB ChB, MD, FBPharmacolS, FACMT
2023 JMT FIT Editor:
Paul Ehlers, MD, MS
JMT Advisory Board:
Charles McKay, MD, FACMT
Anne-Michelle Ruha, MD, FACMT
Feature Editors:
Reviews: Gillian A. Beauchamp, MD, FACMT; Michael Hodgman, MD, FACMT
Addiction Medicine: Leslie Dye, MD, FACMT
Medication Safety: Jeanmarie Perrone. MD, FACMT
Case Reports: Andis Graudins, MB BS, PhD, FACEM,
FACMT Toxicology Case Files: Jeffrey Suchard, MD,
FACMT Research Concepts: David Jang, MD, MSc,
FACMT
Articles You Might Have Missed: Daniel Brooks, MD
The Poison Pen: Lewis Nelson, MD, FACMT
Statistics: Mark Su, MD, MPH, FACMT
FIT Editor Program:Trevonne Thompson, MD, FACMT
Social Media & Emerging Technologies: Peter R. Chai, MD, FACMT
Veterinary Toxicology: Wilson Rumbeiha

Medical Toxicology Foundation
(Needs update)
The Medical Toxicology Foundation is fueling the progress and possibilities that are making a difference in our field. As the philanthropic arm of the ACMT, the MTF is where potential meets opportunity, and together, we are helping to meet the demand for pursuing excellence in the field of medical toxicology.
Each year, the MTF offers a range of research funding for innovative projects. We also offer travel award opportunities for students and residents considering a medical toxicology fellowship to attend ACMT’s Annual Scientific Meeting. Now in its third year, the Medical Toxicology in Industry Fellows Rotation done in partnership with Bayer is a unique elective program for medical toxicology fellows to learn more about a career in industry. The growth and interest in this program has been excellent.
Every gift to the MTF makes a lasting impact on the future of medical toxicology research, education, and patient care.
By investing in research, education, and professional development, the MTF plays a crucial role in advancing the field of medical toxicology as a whole.
2024 Grant and Award Recipients (To be updated)
The Medical Toxicology Foundation understands the importance of fostering innovation and supporting the development of talented professionals in the field. Through its research grants, the foundation aims to encourage and fund groundbreaking research projects that have the potential to revolutionize the field of medical toxicology. These grants provide recipients with the necessary resources to conduct in-depth studies, explore new treatment methods, and contribute to the body of knowledge in this critical area of medicine.

2023 MTF/SAEMF Medical Toxicology Grant
Mehruba Parris, MD, FACMT
Assistant Professor of Emergency Medicine, Rutgers New Jersey Medical School (NJMS); medical toxicology consultant, New Jersey Poison Information and Education System
Award Amount: $20,000
Funding Period: July 1, 2023 – June 30, 2024
Project: “Efficacy and Incidence of Adverse Events of High Dose Buprenorphine for MOUD in the ED”
In 2020, according to the Centers for Disease Control and Prevention (CDC), nearly 69,000 people died from an opioid overdose in the United States (U.S.). Both buprenorphine and methadone reduce mortality due to opioid overdose. The total number of emergency department (ED) visits related to opioid use in the U.S. grew from 2005 to 2017, with the overall rate increase from 89.1 to 249.1 per 100,000 population. Due to the prevalence of opioid use disorder (OUD) within many EDs across the country, initiating medications for opioid use disorder (MOUD) using buprenorphine in the ED provides the opportunity to reach many patients, particularly those who may not successfully attend an initial outpatient appointment. The current recommended dosing regimen of 2 to 4 mg every 2 hours to a maximum dose of 12 mg for induction is impractical in the ED and carries a high risk of precipitated opioid withdrawal if initiated prior to the development of moderate opioid withdrawal and higher probability of falling out of treatment due to the length and inefficacy of the method. Because buprenorphine has a higher binding affinity for the mu-opioid receptors than full opioid agonists, initiating treatment with a high dose of buprenorphine to replace opioid agonists bound to mu-opioid receptors should prevent precipitated withdrawal in those with early, mild opioid withdrawal.
At our institution high dose buprenorphine use in early withdrawal is a common, guideline-driven practice, although there is limited published literature. The goal of this study is to contribute safety and efficacy data regarding high dose buprenorphine initiation within the ED, particularly in OUD patients in mild or no withdrawal (COWS<8). The use of high-dose buprenorphine as MOUD for patients within the ED appears to be safe, decrease length of stay, and make MOUD more accessible.
Applications for this grant are accepted between May 1st and August 1st each year.
The MTF offers several conference travel awards for medical students and residents to offset cost to attend ACMT’s Annual Scientific Meeting (ASM). Attending these conferences provides opportunities to network with experts in the field, and recipients gain exposure to the latest advancements, emerging trends, and best practices in medical toxicology. to encourage residents to pursue medical toxicology fellowship training.
The MTF offers several conference travel awards for medical students and residents to offset cost to attend ACMT’s Annual Scientific Meeting (ASM). Attending these conferences provides opportunities to network with experts in the field, and recipients gain exposure to the latest advancements, emerging trends, and best practices in medical toxicology. to encourage residents to pursue medical toxicology fellowship training.
The MTF offers several conference travel awards for medical students and residents to offset cost to attend ACMT’s Annual Scientific Meeting (ASM). Attending these conferences provides opportunities to network with experts in the field, and recipients gain exposure to the latest advancements, emerging trends, and best practices in medical toxicology. to encourage residents to pursue medical toxicology fellowship training.
The MTF offers several conference travel awards for medical students and residents to offset cost to attend ACMT’s Annual Scientific Meeting (ASM). Attending these conferences provides opportunities to network with experts in the field, and recipients gain exposure to the latest advancements, emerging trends, and best practices in medical toxicology. to encourage residents to pursue medical toxicology fellowship training.
2025 J&J Consumer Health Diversity, Equity & Inclusion Travel Awardees

Mounir Contreas Cejin, MD
Resident, University of Texas Southwestern

Annie Hoang, MD
Resident, University of California, Los Angeles

Jennifer Thompson, MD
Resident, University of New Mexico Hospital
2024 Dr. Michael Shannon Diversity, Equity and Inclusion Travel Award

Hector Barreto-Vazquez, MD
Resident, Baylor College of Medicine
Michael P. Spadafora Medical Toxicology Travel Award

Brian Slayyeh, DO
Emergency Medicine Resident,
University of Arkansas for Medical Sciences
Medical Toxicology in Industry Program Fellows
The focus of this program is to create opportunities for fellows to experience another facet of medical toxicology during their fellowship and introduce them to the possibility of a career in industry. The goal is to teach the principles of product development from the R&D pipeline, through the regulatory process, to launch and post-market stewardship. The rotation will address the gap in understanding the role of industry and the regulatory oversight of bringing important technology from the academic arena to the public sphere.
February 2023 Rotation

Adiel Aizenberg, MD
University of Arizona and Banner University Medical System, Tucson, AZ

Juliana Chang, MD
Northwell Health, Manhasset, NY

Frank Dicker, MD
Washington University School of Medicine, St. Louis, MO

Ryan Fuchs, MD
HealthPartners Institute, Minneapolis, MN
October 2023 Rotation

John Keller, MD
University California San Francisco, San Francisco, CA

Alexander Lazar, MD
Washington University, St. Louis, MI

Serah Wambui Oyewole, MD
University of Texas Southwestern, Dallas, TX

Stephen Petrou, MD
The Charles E. Becker Medal for Outstanding Achievement as a Medical Toxicology Fellow

Courtney Temple, MD was selected as the inaugural recipient of the Charles E. Becker Medal for Outstanding Achievement as a Medical Toxicology Fellow. This new award was established with the generous support of the late Dr. Charles Becker, a pioneering leader in the field of medical toxicology. In keeping with his vision, the Becker Medal recognizes a recently graduated medical toxicology fellow who has demonstrated outstanding achievement in scholarship, education, and/or research, and who has made contributions to public health, innovation, humanitarianism, and/or “making a positive difference in the world.” Dr. Temple completed the Medical Toxicology Fellowship program at Oregon Health and Science University in 2022. She is currently an Assistant Professor of Emergency Medicine at OHSU and a member of the core faculty of the OHSU Medical Toxicology Fellowship Program. Dr. Temple received the Becker Medal during a ceremony at the 2023 ACMT Annual Scientific Meeting in La Jolla, CA.

Financial Report
Funders, Partners, and Supporters
FEDERAL FUNDERS & PARTNERS
Agency for Toxic Substances and Disease Registry (ATSDR)
Battelle Memorial Institute
Centers for Disease Control and Prevention / National Center for Injury Prevention and Control (CDC/NCIPC)
Food & Drug Administration (FDA)
National Institute of Health /National Institute of Drug Abuse (NIH/NIDA)
Substance Abuse and Mental Health Services Administration (SAMHSA)
CORPORATE FUNDERS & EXHIBITORS
AstraZeneca
Bayer U.S. Crop Science
BTG International, Inc.
Johnson & Johnson Consumer Inc.
Rare Disease Therapeutics
SUPPORTERS / COLLABORATORS
American Academy for Addiction Psychiatry (AAAP)
American Academy of Clinical Toxicology (AACT)
American Academy of Emergency Medicine (AAEM)
American Academy of Pediatrics (AAP)
America’s Poison Centers (APC)
American Society of Addiction Medicine (ASAM)
European Association of Poison Centres and Clinical Toxicologists (EAPCCT)
Icahn School of Medicine at Mount Sinai
Radiation Emergency Assistance Center/Training Site (REAC/TS)
Patient-Centered Outcomes Research Institute (PCORI)
Springer
University of Massachusetts
2023 ACMT Balance Sheet
Totals as of December 31, 2023
ASSETS | TOTAL |
Total Bank Accounts | $ 2,907,121 |
Total Accounts Receivable | $ 329,596 |
Investment Account | $ 1,498,057 |
Total Prepaid Expenses | $ 46,790 |
Temporary Restricted Net Assets | $ 3,000 |
TOTAL ASSETS | $ 4,784,564 |
Total Accounts Payable | $ 98,818 |
Total Credit Cards | $ 8,017 |
Accumulated PTO Payable | $ 108,927 |
Total Deferred Course Revenue | $ 51,663 |
Total Deferred Dues Revenue | $ 133,320 |
Deferred Income | $ 438,037 |
Due to/from MTF | $ -99,992 |
Unbilled Revenue | $ -81,512 |
TOTAL LIABILITIES | $ 657,276 |
Equity | |
Retained Earnings | $ 3,739,293 |
Temporarily Restricted Net Assets | $ 6,000 |
Net Income | $ 381,994 |
Total Equity | $ 4,127,287 |
TOTAL LIABILITIES AND EQUITY | $ 4,784,564 |